Plus, rheumatology drug news from EULAR 2014
EULAR 2014: Biosimilar Drug Production Raises Concerns
Rheumatology experts question biosimilars’ safety, efficacy given their complex production process
EULAR 2014: Research on Rheumatoid Arthritis, Spondyloarthritis
Latest findings on rheumatological drug therapies, including methotrexate for RA, tumor necrosis factor inhibitors for SpA
Rheumatology Drug Updates, Trials, Safety Data
An update on baricitinib, plus safety warnings on belimumab,
eszopiclone and zoledronic acid
Rheumatology Drug Updates, Trials, Safety Data
Legislative news on biosimilars, safety warning on epidural corticosteroid injections, and other drug updates rheumatologists need to know
Rheumatology Drug Updates, Trials, Safety Data
Information on oral anticoagulant apixaban, apremilast for active psoriatic arthritis, hyaluronic acid and methotrexate injections, and drug safety updates rheumatologists need to know
Rheumatology Drug Updates, Trials, Safety Data
Information on acetaminophen restrictions; trials for clazakizumab, epratuzumab, romosozumab; and drug safety updates rheumatologists need to know
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
- « Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- …
- 13
- Next Page »